Literature DB >> 6546329

Vitamin D conversion by sarcoid lymph node homogenate.

R S Mason, T Frankel, Y L Chan, D Lissner, S Posen.   

Abstract

Recent studies suggest that hypercalcemia of sarcoidosis is due to high blood concentrations of calcitriol and that this compound may be synthesized at an extra-renal site. We report that sarcoid lymph node homogenate metabolized calcifediol to a substance indistinguishable from calcitriol, whereas six nonsarcoid lymph nodes failed to produce this compound.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6546329     DOI: 10.7326/0003-4819-100-1-59

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  36 in total

Review 1.  Hormones and the immune response.

Authors:  A K Bhalla
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

2.  Hypercalcaemia and sarcoidosis in infancy.

Authors:  S J Stanworth; C T Kennedy; P A Chetcuti; F Carswell
Journal:  J R Soc Med       Date:  1992-03       Impact factor: 5.344

Review 3.  1,25-Dihydroxyvitamin D-related hypercalcemia in lymphoma: two case reports.

Authors:  J P Devogelaer; M Lambert; B Boland; C Godfraind; H Noel; C Nagant de Deuxchaisnes
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

4.  Chest diseases: sarcoidosis and hypercalcemia.

Authors:  O P Sharma
Journal:  West J Med       Date:  1986-03

5.  Sarcoidosis presenting with an unusual erythematous rash and persistent hypercalcemia.

Authors:  B L Barney
Journal:  West J Med       Date:  1992-05

Review 6.  Clinical impact of bone and calcium metabolism changes in sarcoidosis.

Authors:  G Rizzato
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

7.  Tumor products and the hypercalcemia of malignancy.

Authors:  G R Mundy; K J Ibbotson; S M D'Souza
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

Review 8.  Vitamin D-endocrine system.

Authors:  N H Bell
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

9.  [Renal manifestations in rheumatic diseases].

Authors:  K de Groot
Journal:  Internist (Berl)       Date:  2007-08       Impact factor: 0.743

Review 10.  Hypercalcaemia of malignancy.

Authors:  P J Kelly; J A Eisman
Journal:  Cancer Metastasis Rev       Date:  1989-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.